Christopher S. Belder
UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 30, 2026
Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 18, 2026
Comparing amyloid immunotherapy with cholinesterase inhibitors for Alzheimer's disease.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 16, 2026
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: June 17, 2025
Ultra-fast MRI for dementia diagnosis and treatment eligibility: A prospective study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 10, 2025
Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority - Authors' reply.
Journal: The Lancet. Neurology
Published: January 14, 2025
The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 07, 2023
Primary progressive aphasia: six questions in search of an answer.
Journal: Journal of neurology
Published: September 16, 2023
Last Updated: 09/26/2026